Speciality: Hematology
Description:
A warm welcome to all the medical professionals in this insightful session on understanding the intricate relationship between cardiovascular and systemic health. This Virtual Case Study on Pedal Edema and Triple Vessel Disease, an initiative by Hidoc Dr., is designed to provide a practical, deep dive into a complex clinical scenario. The case highlights how a seemingly simple symptom like pedal edema can be a critical indicator of a severe underlying condition, in this instance, triple vessel disease (TVD), a form of coronary artery disease.
The case study will explore the diagnostic journey, from initial patient presentation with lower limb swelling to a conclusive diagnosis of TVD. We will examine the importance of a thorough clinical evaluation, including a detailed history, and the use of diagnostic tools such as electrocardiograms (ECG), echocardiograms, and ultimately, coronary angiography. This discussion will underscore how edema, a sign of fluid overload often linked to heart failure, can be a direct consequence of the heart's compromised pumping efficiency due to blockages in all three major coronary arteries.
Therefore, get a comprehensive understanding of how to connect seemingly disparate symptoms to a complex diagnosis. Engage with this virtual case study, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Q&A: Nipple-Sparing Mastectomy After Breast Radiation
2.
Resection for Early Liver Cancer Tied to Improved Survival.
3.
Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening
4.
An individual state lost $4.02 billion due to untreated mental illness.
5.
Medical Journal March 29, 2023
1.
Oncologic Emergencies: Diagnosis and Treatment
2.
Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights
3.
Leptomeningeal Carcinomatosis: Symptoms, Causes, and Treatment Options
4.
National Blood Health Promotion Strategies: Evidence-Based Approaches for Improved Outcomes
5.
The Science Behind Thrombolytic Drugs and Their Benefits
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
3.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
4.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
5.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation